Kidswell BioTSE:4584 +4.90%44 PS Ratio is 1.13 as of Jul. 12, 2026, which is 88% below its 10-year median of 9.17. GuruFocus rates TSE:4584 with a GF Score™ of 44/100 and a GF Value™ of 円232.03 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 930 Biotechnology companies, Kidswell Bio ranks better than 91.51% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Kidswell Bio's share price is 円150.00.
Kidswell Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円133.30. Hence, Kidswell Bio's PS Ratio for today is 1.13.
Good Sign:
Kidswell Bio Corp stock PS Ratio (=1.11) is close to 1-year low of 1.
The historical rank and industry rank for Kidswell Bio's PS Ratio or its related term are showing as below:
TSE:4584'
s PS Ratio Range Over the Past 10 Years
Min: 0.87 Med: 9.17 Max: 30.28
Current: 1.13
During the past 13 years, Kidswell Bio's highest PS Ratio was 30.28. The lowest was 0.87. And the median was 9.17.
TSE:4584's PS Ratio is ranked better than 91.51% of 930
companies
in the Biotechnology industry
Industry Median: 9.51
vs TSE:4584: 1.13
Kidswell Bio Corp revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Kidswell Bio was 7.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 15.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 30.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 5.40% per year.
During the past 13 years, Kidswell Bio's highest 3-Year average Revenue per Share Growth Rate was 126.90% per year. The lowest was -22.30% per year. And the median was 16.75% per year.
Back to Basics: PS Ratio
Kidswell Bio (TSE:4584) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Kidswell Bio PS Ratio Related Terms
Kidswell Bio PS Ratio Historical Data
* Premium members only.
The historical data trend for Kidswell Bio's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Kidswell Bio's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kidswell Bio PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kidswell Bio's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kidswell Bio's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Kidswell Bio's PS Ratio for today is calculated as
Kidswell Bio's Share Price of today is 円150.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kidswell Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円133.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Kidswell Bio (TSE:4584) has a PS Ratio of 1.13 as of Jul. 12, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kidswell Bio and its competitors. This is 88% below median its historical median of 9.17. Over the past decade, Kidswell Bio's PS Ratio has ranged from 0.87 to 30.28. According to the industry distribution chart, Kidswell Bio ranks #79 out of 930 companies in the Biotechnology industry, placing it in the top 8.5%.
Is Kidswell Bio's PS Ratio too high?
Kidswell Bio's current PS Ratio of 1.13 is 88% below median its 10-year median of 9.17. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 30.28. The Biotechnology industry median PS Ratio is 9.51. Kidswell Bio's value of 1.13 is 88.1% below this industry median. Based on the distribution chart, Kidswell Bio ranks #79 out of 930 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kidswell Bio has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kidswell Bio ranks #79 out of 930 companies for PS Ratio. This places Kidswell Bio in the top 9% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.51. Kidswell Bio's value of 1.13 is 88.1% below this benchmark. Historically, Kidswell Bio's own PS Ratio has ranged from 0.87 to 30.28 over the past decade. While the company's 10-year median is 9.17 vs. the industry median of 9.51, Kidswell Bio has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.51, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kidswell Bio's current PS Ratio of 1.13 is 88.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kidswell Bio and its competitors. For the Biotechnology industry, the median PS Ratio is 9.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kidswell Bio's current PS Ratio is 1.13, which is 88% below median its own 10-year median of 9.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Possible Value Trap. The stock's GF Value™ is 円232.03, compared to a current price of 円150.00 — trading 35.4% below its estimated fair value. The current PS Ratio is 1.13, which is 88% below median its 10-year median of 9.17 and 88.1% below the Biotechnology industry median of 9.51. Kidswell Bio's overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current PS Ratio is 1.13 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kidswell Bio (TSE:4584) Overvalued in 2026?
Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued.
The current stock price of 円150.00 is trading 35.4% below its estimated GF Value™ of 円232.03.
GuruFocus considers Kidswell Bio to be Possible Value Trap.
Key valuation signals for TSE:4584:
PS Ratio: 1.13 (88% below median its 10-year median of 9.17)
GF Value™: 円232.03 vs. price of 円150.00 (35.4% below fair value)
Industry Position: 88.1% below the Biotechnology median (#79 of 930)
No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4584 has been successfully added to your 
